B12 Deficiency: How to Diagnose It, What Your Levels Actually Mean, and What to Do Next

Quick Summary

Learn how to accurately diagnose vitamin B12 deficiency using serum B12, MMA, and homocysteine markers. Includes optimal ranges, who's most at risk, supplementation protocols by deficiency stage, and testing timelines.

Your B12 came back at 280 pg/mL. Your doctor glanced at the result, said "normal," and moved on. What they probably didn't mention is that functional B12 deficiency can begin at levels well above the standard cutoff — and that by the time serum B12 drops below the lab's flagged range, neurological damage may already be underway.

Here's the problem with how most people think about B12 vitamins — they assume a single blood test gives a clear yes-or-no answer. It doesn't. Serum B12 alone misses up to 50% of functionally deficient patients because it measures total B12 in the blood, including inactive forms your cells can't use [1]. Meanwhile, the symptoms of early deficiency — fatigue, brain fog, tingling in the hands, mood changes — overlap with dozens of other conditions, so clinicians rarely investigate further unless levels are critically low.

The other gap is supplementation. Most people who suspect low B12 grab a random bottle of cyanocobalamin from the pharmacy shelf. But the right form, dose, and route depend entirely on why you're deficient — and some causes (like pernicious anemia or malabsorption) won't respond to oral supplements at standard doses no matter how many you take.

This guide gives you the complete diagnostic framework for B12 deficiency — which tests to run, what the numbers actually mean, who's most at risk, and what to do at each stage of deficiency. No guessing. No wasted supplementation.

What Is Vitamin B12?

Vitamin B12 (cobalamin) is a water-soluble vitamin required for DNA synthesis, red blood cell formation, myelin maintenance, and methylation — the biochemical process that regulates gene expression, neurotransmitter production, and homocysteine metabolism.

Unlike most vitamins, B12 has a uniquely complex absorption pathway:

1. Stomach acid and pepsin release B12 from food proteins

2. B12 binds to R-proteins (haptocorrins) in saliva and stomach

3. Pancreatic enzymes release B12 from R-proteins in the small intestine

4. B12 binds to intrinsic factor (produced by gastric parietal cells)

5. The B12-intrinsic factor complex is absorbed in the terminal ileum

A breakdown at any of these five steps causes deficiency — which is why B12 deficiency is far more common than dietary intake alone would predict. You can eat adequate B12 and still be deficient if you can't absorb it [2].

Your body stores 2–5 mg of B12, primarily in the liver. Because stores are large relative to daily requirements (2.4 μg/day for adults), deficiency develops slowly — often over 2–5 years — which makes it easy to miss until symptoms become serious.

Why Is B12 Deficiency So Often Missed?

Three structural problems make B12 deficiency one of the most underdiagnosed nutritional conditions in clinical practice.

The Reference Range Problem

Most labs flag serum B12 as "low" only below 200 pg/mL (148 pmol/L). But research consistently shows that neurological and metabolic dysfunction begins at levels below 400–500 pg/mL in many individuals. The gap between "flagged as deficient" and "functionally insufficient" is enormous [3].

The Single-Marker Problem

Serum B12 measures total cobalamin in circulation — both active (holotranscobalamin) and inactive forms bound to haptocorrin. Up to 80% of circulating B12 is in the inactive form. This means serum B12 can appear adequate while your cells are functionally starved.

The Symptom Overlap Problem

Early B12 deficiency produces nonspecific symptoms that mimic stress, aging, depression, thyroid dysfunction, and iron deficiency. Without targeted testing, these symptoms are frequently attributed to other causes or dismissed entirely.

Who Is Most at Risk?

B12 deficiency isn't just a vegan problem. These groups have significantly elevated risk:

• Adults over 50 — gastric acid production declines with age, impairing B12 release from food proteins. Prevalence of low B12 in older adults: 10–30%

• Vegans and strict vegetarians — B12 exists naturally only in animal products. Without supplementation, deficiency is nearly universal within 2–3 years

• People taking metformin — long-term metformin use reduces B12 absorption by 10–30% through calcium-dependent ileal uptake disruption [4]

• People taking PPIs or H2 blockers — acid suppression impairs B12 release from food proteins. Risk increases significantly after 2+ years of use

• Post-bariatric surgery patients — gastric bypass removes or bypasses the sites of intrinsic factor production and B12 absorption

• People with autoimmune conditions — pernicious anemia (anti-intrinsic factor antibodies) and autoimmune gastritis directly block absorption

• People with GI conditions — Crohn's disease (especially ileal involvement), celiac disease, SIBO, and chronic H. pylori infection all impair B12 absorption

• Heavy alcohol users — alcohol damages gastric mucosa and impairs hepatic B12 storage

If you belong to two or more of these groups, assume you need B12 monitoring regardless of symptoms.

The 3-Test Diagnostic Framework

A single serum B12 test is not sufficient for accurate diagnosis. The gold standard is a three-marker panel that catches deficiency at every stage.

Test 1: Serum B12

What it measures: Total circulating cobalamin (active + inactive forms).

When it's useful: As a first-pass screen. If serum B12 is below 300 pg/mL, further testing is warranted. If it's above 600 pg/mL, functional deficiency is unlikely (though not impossible in rare cases).

Limitation: Does not distinguish between active and inactive B12. Can be falsely normal in early functional deficiency.

Test 2: Methylmalonic Acid (MMA)

What it measures: A metabolite that accumulates when B12 is insufficient at the cellular level. B12 is a cofactor for the enzyme that converts methylmalonyl-CoA to succinyl-CoA. When B12 is low, this conversion stalls and MMA rises.

Why it matters: MMA is the most specific functional marker of B12 status. Elevated MMA (> 270 nmol/L) with borderline serum B12 confirms functional deficiency even when serum B12 looks "normal."

Limitation: Mildly elevated in renal insufficiency. Always interpret alongside kidney function.

Test 3: Homocysteine

What it measures: An amino acid metabolized by a B12-dependent enzyme (methionine synthase). When B12 is insufficient, homocysteine accumulates.

Why it matters: Elevated homocysteine (> 10 μmol/L) supports the B12 deficiency diagnosis and independently predicts cardiovascular risk. However, homocysteine also rises with folate deficiency and B6 deficiency, so it's not B12-specific.

The diagnostic rule: If serum B12 is below 300 pg/mL AND MMA is elevated, B12 deficiency is confirmed. If serum B12 is 300–500 pg/mL with elevated MMA, you have subclinical deficiency that warrants treatment. If serum B12 is above 500 pg/mL with normal MMA, you are likely sufficient.

Track Your B12 Status

Mito Health tests serum B12, homocysteine, and a full metabolic panel with physician-guided interpretation — so you get the complete picture of your B12 status, not just a single number flagged against an outdated reference range. Individual testing starts at $349 and duo testing starts at $668.

View Testing Options →

Symptoms by Deficiency Stage

B12 deficiency progresses through distinct stages. Recognizing where you fall determines the urgency and intensity of treatment.

Stage 1: Depleted Stores (Often Asymptomatic)

Liver B12 stores decline. Serum B12 may still appear normal. MMA begins to rise. Most people feel nothing at this stage, which is why routine screening matters for high-risk groups.

Stage 2: Early Functional Deficiency

Cellular B12 becomes insufficient. Symptoms emerge:

• Persistent fatigue not explained by sleep or iron status

• Difficulty concentrating, brain fog

• Mild mood changes — irritability, low motivation

• Subtle balance or coordination changes

These symptoms are routinely attributed to stress or aging. Without B12 testing, the real cause goes undetected.

Stage 3: Clinical Deficiency

Measurable hematological and neurological changes:

• Macrocytic anemia — MCV > 100 fL, elevated red blood cell size

• Peripheral neuropathy — numbness, tingling, or burning in hands and feet

• Glossitis — smooth, swollen, red tongue

• Angular cheilitis — cracks at the corners of the mouth

• Cognitive impairment — memory loss, difficulty with word-finding

Stage 4: Severe or Prolonged Deficiency

• Subacute combined degeneration of the spinal cord

• Severe cognitive decline mimicking dementia

• Psychiatric symptoms — paranoia, hallucinations, severe depression

• Pancytopenia — reduction in all blood cell lines

Critical point: Neurological damage from B12 deficiency can become irreversible if left untreated for more than 6–12 months at Stage 3–4. Early detection and treatment prevents permanent harm [5].

What to Do: Supplementation Protocols by Deficiency Stage

The right intervention depends on why you're deficient and how severe it is. One-size-fits-all dosing is the most common mistake.

Choosing the Right Form

For most people supplementing orally, methylcobalamin or a methylcobalamin/adenosylcobalamin combination is the best choice. Cyanocobalamin works but requires more metabolic conversion and releases trace cyanide (clinically insignificant at normal doses, but unnecessary when better forms exist).

For a deeper comparison of B12 supplement forms, see our B12 form comparison guide.

Protocol by Stage

Subclinical deficiency (serum B12 300–500 pg/mL, MMA mildly elevated):

• Methylcobalamin 1,000 μg sublingual daily for 8 weeks

• Retest serum B12 and MMA at 8 weeks

• If normalized, continue 500 μg daily maintenance

Clinical deficiency (serum B12 < 300 pg/mL, symptoms present):

• Methylcobalamin 2,000–5,000 μg sublingual daily for 4 weeks, then reduce to 1,000 μg daily

• If neurological symptoms are present: consider hydroxocobalamin injections (1,000 μg IM weekly for 4 weeks, then monthly)

• Retest at 4 weeks and 12 weeks

Malabsorption-driven deficiency (pernicious anemia, post-bariatric, Crohn's):

• Oral supplementation may be insufficient regardless of dose

• Hydroxocobalamin injections 1,000 μg IM every other day for 2 weeks, then weekly for 4 weeks, then monthly indefinitely

• High-dose oral (2,000–5,000 μg daily) can work for some malabsorbers through passive diffusion (about 1% of oral dose is absorbed passively), but response must be confirmed by retesting [6]

Vegan or vegetarian maintenance (no current deficiency):

• Methylcobalamin 500–1,000 μg sublingual daily, or 2,500 μg twice weekly

• Annual B12 and MMA monitoring

Timing and Absorption Tips

• Sublingual tablets dissolve under the tongue and partially bypass GI absorption — preferred over standard oral tablets for anyone with suspected malabsorption

• Take B12 on an empty stomach or between meals for best absorption

• B12 does not compete with other supplements for absorption — safe to take alongside other vitamins

• High-dose B12 supplementation turns urine bright pink or red. This is normal and harmless

Testing Timeline: When to Retest

Expected response: Serum B12 should rise significantly within 2–4 weeks of adequate supplementation. MMA should normalize within 4–8 weeks. Neurological symptoms may take 3–6 months to fully resolve, and some nerve damage may be permanent if treatment was delayed beyond 12 months.

Common Mistakes

• Relying on serum B12 alone — you need MMA to confirm functional status. A "normal" serum B12 of 350 pg/mL with elevated MMA is still deficiency.

• Taking cyanocobalamin when methylcobalamin is available — not dangerous, but suboptimal. Why add a conversion step your body doesn't need?

• Stopping supplementation after levels normalize — if the root cause (vegan diet, malabsorption, PPI use) persists, deficiency will return. B12 supplementation is often lifelong.

• Ignoring the cause — supplementation treats the deficiency but not the disease. If you're not vegan and your B12 is low, investigate why: pernicious anemia antibodies, GI workup, medication review.

• Assuming more is always better — serum B12 above 1,000 pg/mL from supplementation is generally harmless, but persistently high B12 without supplementation warrants investigation for liver disease or myeloproliferative disorders [7].

The Bottom Line

B12 deficiency is common, underdiagnosed, and progressive. The standard lab reference range misses subclinical deficiency in a large percentage of cases, and serum B12 alone is not a reliable diagnostic test.

The correct approach:

1. Test serum B12, MMA, and homocysteine — not just serum B12

2. Use the functional cutoff of 500 pg/mL for optimal status, not the lab's lower limit of 200 pg/mL

3. Identify the cause — diet, malabsorption, medication, or autoimmune

4. Match the supplementation protocol to the cause and severity

5. Retest to confirm response, and continue monitoring if the underlying cause persists

If you're over 50, vegan, taking metformin or PPIs, or experiencing unexplained fatigue, brain fog, or neuropathy — get tested. B12 deficiency is one of the most treatable causes of cognitive and neurological decline, but only if you catch it before the damage becomes permanent.

Key Takeaways

• Serum B12 alone misses up to 50% of functionally deficient patients — always add MMA for confirmation

• The optimal longevity range for serum B12 is 500–900 pg/mL, far above the standard lab cutoff of 200 pg/mL

• B12 deficiency progresses through four stages, from depleted stores to irreversible neurological damage

• Methylcobalamin is the preferred supplementation form for most people; injections are necessary for malabsorption

• Adults over 50, vegans, metformin users, and PPI users should monitor B12 annually regardless of symptoms

• Neurological damage from B12 deficiency can become irreversible after 6–12 months — early detection is critical

• Supplementation is often lifelong if the root cause of deficiency persists

Check Your B12 Status

Mito Health tests Active B12 (Holotranscobalamin), MMA, Homocysteine, and related markers with physician-guided interpretation. Catch deficiency before symptoms become irreversible.

View Testing Options →

Medical Disclaimer

This guide is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Vitamin B12 deficiency can have serious medical consequences including irreversible neurological damage. Always consult a qualified healthcare provider before starting or changing supplementation, especially if you have symptoms of neuropathy, anemia, or cognitive decline. Do not use this guide as a substitute for professional medical evaluation.

Track Your Progress

Monitor your B12 status alongside related markers to get the full picture:

• Vitamin B12 — track your serum levels over time

• Homocysteine — an independent cardiovascular risk marker that rises with B12, folate, or B6 deficiency

• Improve your Vitamin B12 — actionable strategies for optimizing B12 status

• Folate — B12 and folate metabolism are tightly linked; deficiency in one masks the other

• MCV (Mean Corpuscular Volume) — elevated MCV is an early hematological sign of B12 deficiency

Related Content

• Which B12 Form Should You Take? Complete Comparison Guide

• How to Raise Your Vitamin B12 Levels: Evidence-Based Methods

• Homocysteine: What Your Levels Mean and How to Lower Them

• Iron Deficiency vs. B12 Deficiency: How to Tell the Difference

• Complete Blood Count: What Your CBC Results Mean

References

1. Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr. 2011;94(1):348S-358S. PMID: [21593511](https://pubmed.ncbi.nlm.nih.gov/21593511/)

1. Green R, Allen LH, Bjørke-Monsen AL, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040. PMID: [28660890](https://pubmed.ncbi.nlm.nih.gov/28660890/)

1. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318(26):1720-1728. PMID: [3374544](https://pubmed.ncbi.nlm.nih.gov/3374544/)

1. Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. PMID: [26900641](https://pubmed.ncbi.nlm.nih.gov/26900641/)

1. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991;70(4):229-245. PMID: [1648656](https://pubmed.ncbi.nlm.nih.gov/1648656/)

1. Eussen SJ, de Groot LC, Clarke R, et al. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch Intern Med. 2005;165(10):1167-1172. PMID: [15911731](https://pubmed.ncbi.nlm.nih.gov/15911731/)

1. Arendt JFB, Pedersen L, Nexo E, Sørensen HT. Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. J Natl Cancer Inst. 2013;105(23):1799-1805. PMID: [24249744](https://pubmed.ncbi.nlm.nih.gov/24249744/)

1. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149-160. PMID: [23301732](https://pubmed.ncbi.nlm.nih.gov/23301732/)